Status:
RECRUITING
Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Multiple Myeloma
Monocytes
Eligibility:
All Genders
18+ years
Brief Summary
Tumoral micro-environment in malignant haematological diseases, notably in multiple myeloma, is active on plasma cells survival and proliferation. Monocytosis and monocytes typing are described in mul...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients over 18 years old
- Treated for a multiple myeloma
- CART cells treatment proposed
- Affiliated to social security system
- Agreed to participate to the study
Exclusion
Key Trial Info
Start Date :
July 16 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT07180992
Start Date
July 16 2025
End Date
September 1 2028
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Amiens
Amiens, France